SCHEMBL7989418

SCHEMBL7989418

O=c1[nH]c(-c2cccnc2)nc2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 1/20 0.43
PKM P14618 2/20 0.42
PNP P00491 1/20 0.42
HPGD P15428 3/20 0.42
MAPT P10636 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
GSK3B P49841 1/20 0.39
MET P08581 1/20 0.39
DHPS P49366 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
CHEK1 O14757 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974283 0.90 ALDH1A1 (0.53) SMN1; SMN2ALDH1A1KMT2APNPHPGD
SCHEMBL7984766 0.90 HPGD (0.44) SMN1; SMN2ALDH1A1KMT2APNPHPGD
SCHEMBL7985331 0.89 GRIN1 (0.45) SMN1; SMN2ALDH1A1KMT2APKMPNP
SCHEMBL7986518 0.88 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2APNPHPGD
SCHEMBL7985270 0.87 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDCNOT7
SCHEMBL7974236 0.87 ABCC8 (0.43) SMN1; SMN2ALDH1A1KMT2APNPHPGD
SCHEMBL7984279 0.87 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDCYP11B2
SCHEMBL7988732 0.85 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDCYP11B1
SCHEMBL7988656 0.85 NPY5R (0.44) SMN1; SMN2ALDH1A1KMT2APNPHPGD
SCHEMBL7985116 0.84 HPGD (0.44) SMN1; SMN2ALDH1A1KMT2APNPHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed